NEWSLETTER SIGN-UP
Type in your Email: 
Rydium Member
Breaking News  |  Articles  |  Products  |  BBS/Forums  |  Press Releases 
Friday May 16, 2008

If you have any news you think might be interesting, email to staff@transmetazone.com

Previous News:
Search News:
 Transmeta Corporation Schedules First Quarter 2008 Earnings Release & Conference Tue May 06, 11:55:33 AM  
   Author: M. Page

Transmeta Corporation Schedules First Quarter 2008 Earnings Release & Conference Call

Transmeta Corporation (NASDAQ: TMTA) today announced that it will release its earnings results for the first quarter ended March 31, 2008 after the NASDAQ market closes on Thursday, May 8, 2008.

Following the release, Transmeta's management will host a conference call at 5:00 p.m. Eastern time / 2:00 p.m. Pacific time. The conference call will be available live over the Internet at the investor relations section of Transmeta's website at www.transmeta.com. To listen to the conference call, please dial (913) 312-0822. A recording of the conference call will be available for one week, starting one hour after the completion of the call, until 11:59 p.m. Pacific time on May 15, 2008. The phone number to access the recording is (719) 457-0820, and the passcode is 8889410.

Source: transmeta  
Category: Business / Industry [ next ] [ top ] [ bottom ]

 Transmeta Reports Fourth Quarter and Fiscal 2007 Results Tue Mar 18, 03:49:36 PM  
   Author: M. Page

Transmeta Reports Fourth Quarter and Fiscal 2007 Results

Transmeta Corporation (NASDAQ:TMTA) today announced financial results for the fourth quarter and fiscal year ended December 31, 2007.

Fiscal 2007 and Recent Highlights

  • Streamlined and restructured Transmeta's operations to focus on its core business of developing and licensing intellectual property and technology.
  • Focused on developing its technology, building its licensing business and putting the building blocks in place to expand its customer base.
  • Received commercial royalty revenue from its first LongRun2 licensee in 2007 and expects first volume production royalty revenue in the first quarter of 2008.
  • Continued building its U.S. patent portfolio, adding 26 issued patents in 2007, bringing the total to 116 by year end. The Company has since had an additional 18 U.S. patents issue in 2008, bringing its current U.S. patent total to 134.
  • Appointed an executive team to implement and execute on its restructuring program, including Les Crudele as president and chief executive officer, Sujan Jain as chief financial officer, and Dan Hillman as vice president of engineering.
  • Retained Piper Jaffray & Co. as financial advisors to help identify options for enhancing shareholder value.
  • Resolved its patent litigation with Intel, resulting in total payments of $250 million to Transmeta over a five-year period. The Company expects to recognize $234.6 million ratably over the next ten years as an operating gain, and a total of $15.4 million of interest income from 2008 to 2013.

“In 2007 we successfully streamlined and restructured our operations to focus on our core business of developing and licensing intellectual property and technology,” said Les Crudele, president and CEO. “We also resolved our patent litigation with Intel, resulting in total payments of $250 million that Transmeta will receive from Intel over a five year period. As a result of the restructuring, the strength of our IP portfolio and significant increase in cash, Transmeta now has a strong foundation from which we can work to increase shareholder value.

“We are very pleased that the first commercial product licensed to use our LongRun2 technologies is now in volume production. We are developing IP components and tools to help accelerate the implementation of LongRun2 technologies by our licensees, to put the building blocks in place that will enable us to target a broader base of customers for our LongRun2 technologies and to strengthen our patent portfolio. In addition, we are working with our financial advisors to explore and evaluate options for enhancing shareholder value,” said Mr. Crudele.

2007 Year End Financial Results

Revenue for 2007 was $2.5 million, compared with $48.6 million in 2006. The decrease in revenue between 2006 and 2007 was primarily due to the discontinuation of our engineering services and product sales businesses, as well as reduced license revenue. License revenue was $103,000 in 2007, compared with $10.0 million in 2006. Services revenue was $2.2 million in 2007, compared with $36.9 million in 2006. Product revenue was $167,000 in 2007, compared with $1.7 million in 2006.

Net loss attributable to common shareholders for 2007 was $66.8 million, or a loss of $6.33 per share, compared with a net loss of $23.5 million, or a loss of $2.40 per share in 2006. All share and per share data included in this press release have been retroactively adjusted to account for the effect of the one-for-20 reverse stock split that the Company effected on August 17, 2007.

Q4 2007 Financial Results

Revenue for the fourth quarter of 2007 was $126,000. Fourth quarter revenue included: $102,000 of license revenue, $100,000 of which was a one-time non-LongRun2-related technology license and $2,000 of which was license revenue for sample production royalty payments; and $24,000 of service revenue. This compared with revenue of $44,000 in the third quarter of 2007, which included $1,000 of license revenue and $43,000 of service revenue.

Total operating expenses for the fourth quarter of 2007 were $20.9 million, compared with $9.3 million in the third quarter of 2007. Fourth quarter operating expenses included $15.3 million in expenses related to the litigation and resolution of its lawsuit with Intel, non-cash charges of $1.7 million for amortization of intangible assets, and non-cash stock compensation charges of $0.7 million.

The Company’s provision for income taxes for the fourth quarter of 2007 was $3.3 million. Net loss attributable to common shareholders for the fourth quarter of 2007 was $23.9 million, or $1.99 per share, compared with a net loss of $12.7 million, or a loss of $1.24 per share, in the third quarter of 2007.

The Company’s cash, cash equivalents and short term investments at December 31, 2007 totaled $18.6 million. Cash at December 31, 2007 does not include the initial payment of $150.0 million Transmeta received from Intel on January 28, 2008 pursuant to the Companies’ definitive settlement agreement. The Company ended the year with approximately $259 million in total assets. The increase in total assets between 2006 and 2007 were primarily due to the recognition of the present value of expected future payments from Intel as other receivables. Transmeta continues to be debt free.

In view of recent developments in the financial markets, Transmeta has invested its cash equivalents and short-term investments – including the initial payment from Intel – in conservative investment instruments, including a portion in U.S. Treasury Bills.

Accounting Treatment of Litigation Proceeds

In October 2007, Transmeta entered into an agreement with Intel Corporation providing for a settlement of all claims between the two companies and for the licensing of the Transmeta patent portfolio to Intel for use in current and future Intel products. Pursuant to the settlement, Transmeta received the initial $150 million payment on January 28, 2008, and expects annual payments of $20 million each on January 31st of years 2009 to 2013, for total payments of $250 million. Transmeta expects to recognize $234.6 million as an operating gain from the litigation settlement ratably over the ten year capture period for the years 2008 through 2017, and $15.4 million of interest income over the payment period from 2008 to 2013. The Company recognized $3.3 million in tax expense in the fourth quarter of 2007.

The Company expects to recognize $5.87 million in operating gain from the Intel settlement for each of the four quarters of 2008, for a total of $23.46 million. The Company also expects to recognize approximately $1.7 million, $1.1 million, $1.2 million and $1.2 million during the four quarters of 2008, respectively, in imputed interest income from the Intel settlement for a total of $5.2 million. This imputed interest income will be in addition to the interest income that the Company expects to earn on its cash, cash equivalents and short-term investments. Transmeta expects to be profitable on a GAAP net income basis in 2008.

Conference Call

Transmeta’s management will host a conference call today at 4:30 p.m. Eastern time / 1:30 p.m. Pacific time to discuss the operating performance for the quarter. The conference call will be available live over the Internet at the investor relations section of Transmeta's website at www.transmeta.com. To listen to the conference call, please dial (913) 312-1298. A recording of the conference call will be available for one week, starting one hour after the completion of the call, until 11:59 p.m. Pacific time on March 20, 2008. The phone number to access the recording is (888) 203-1112, and the passcode is 2747234. For callers outside the U.S., please dial (719) 457-0820, with the same passcode.

About Transmeta Corporation

Transmeta Corporation develops and licenses innovative computing, microprocessor and semiconductor technologies and related intellectual property. Founded in 1995, we first became known for designing, developing and selling our highly efficient x86-compatible software-based microprocessors, which deliver a balance of low power consumption, high performance, low cost and small size suited for diverse computing platforms. We are presently focused on developing and licensing our advanced power management technologies for controlling leakage and increasing power efficiency in semiconductor and computing devices, and in licensing our computing and microprocessor technologies to other companies. To learn more about Transmeta, visit www.transmeta.com.

Safe Harbor Statement

This release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements speak only as of the date of this release, and we will not necessarily provide updates of our projections or other forward-looking statements. Investors are cautioned that such forward-looking statements are subject to many risks and uncertainties, and may differ materially or adversely from our actual results or future events. Important risk factors that could have material or adverse effects on our results include practical difficulties in implementing our restructuring plan and modifying our business model, the potential loss of key technical and business personnel, uncertainty about the adoption and market acceptance of our technology offerings by current and potential customers and licensees, our inability to predict or ensure that third parties will license our technologies or use our technologies to generate royalties, difficulties in developing our technologies in a timely and cost effective manner, patents and other intellectual property rights, and other risk factors. We urge investors to review our filings with the Securities and Exchange Commission, including our most recent reports on Forms 10-K, 10-Q and 8-K, which describe these and other important risk factors that could have an adverse effect on our results. We undertake no obligation to revise or update publicly any forward-looking statement for any reason.

Transmeta and LongRun2 are trademarks of Transmeta Corporation. All other product or service names mentioned herein are the trademarks of their respective owners.

Transmeta Corporation
Consolidated Balance Sheets
(In thousands)
(Unaudited)
     
December 31, 2007

September 30, 2007 December 31, 2006
 
ASSETS
Current assets:
Cash and cash equivalents $ 15,607 $ 19,629 $ 11,595
Short-term investments 2,968 8,976 29,955
Accounts receivable 163 45 310
Other receivables, current 149,400 - -
Prepaid expenses and other current assets   2,476     2,332     2,729  
Total current assets 170,614 30,982 44,589
 
Other receivables, long-term 85,200 - -
Property and equipment, net 284 376 758
Patents and patent rights, net 2,388 4,100 9,234
Other assets   800     1,010     2,148  
TOTAL ASSETS $ 259,286   $ 36,468   $ 56,729  
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
Accounts payable $ 341 $ 2,171 $ 1,467
Accrued compensation 15,351 834 3,245
Deferred income, net - - 15
Income taxes payable 3,306 4 49
Other accrued liabilities 1,028 4,384 2,966
Current portion of deferred operating gain 23,460 - -
Advances from customers - - 1,320
Current portion of accrued restructuring costs 1,592 2,592 1,996
Current portion of long-term payable   667     600     667  
Total current liabilities 45,745 10,585 11,725
 
Long-term deferred operating gain, net of current portion 211,140 - -
Long-term accrued restructuring costs, net of current portion - - 988
Long-term payable, net of current portion   800     1,000     1,333  
Total liabilities   257,685     11,585     14,046  
 
Stockholders' equity:
Convertible preferred stock 6,966 6,966 -
Common stock 739,268 738,625 724,229
Treasury stock (2,439 ) (2,439 ) (2,439 )
Accumulated other comprehensive gain (loss) 29 29 (66 )
Accumulated deficit   (742,223 )   (718,298 )   (679,041 )
Total stockholders' equity   1,601     24,883     42,683  
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 259,286   $ 36,468   $ 56,729  
Transmeta Corporation
Consolidated Statements of Operations
(Dollars in thousands, except per share data)
(Unaudited)
         
Three Months Ended Years Ended
December 31, 2007 September 30, 2007 December 31, 2006 December 31, 2007 December 31, 2006
Revenue:
Product $ - $ - $ 216 $ 167 $ 1,673
License 102 1 - 103 10,000
Service   24     43     2,177     2,210     36,877  
Total revenue

  126     44     2,393     2,480     48,550  
 
Cost of revenue
Product (1)

- - 194 80 303
License - - - - 39
Service (1)

11 18 1,473 1,247 22,062
Impairment charge on inventories   -     -     1,802     364     1,802  
Total cost of revenue

  11     18     3,469     1,691     24,206  
Gross profit (loss)   115     26     (1,076 )   789     24,344  
Gross margin % 91.3 % 59.1 % -45.0 % 31.8 % 50.1 %
 
Operating expenses:
Research and development (1)

1,981 1,336 7,261 10,790 20,120
Selling, general and administrative (1)

17,236 6,107 5,038 35,093 21,472
Restructuring charges, net 1 177 486 8,879 876
Amortization of patents and patent rights 1,712 1,711 1,712 6,846 6,846
Impairment charge on long-lived and other assets   -     -     800     302     800  
Total operating expenses

  20,930     9,331     15,297     61,910     50,114  
Operating loss (20,815 ) (9,305 ) (16,373 ) (61,121 ) (25,770 )
Interest income and other, net 138 250 625 1,247 2,456
Interest (expense)   53     (15 )   (97 )   -     (98 )
Income (loss) before income taxes (20,624 ) (9,070 ) (15,845 ) (59,874 ) (23,412 )
Provision for income taxes   3,301     3     56     3,308     86  
Net income (loss) (23,925 ) (9,073 ) (15,901 ) (63,182 ) (23,498 )
Deemed dividend for beneficial conversion feature of preferred stock   -     (3,630 )   -     (3,630 )   -  
Net income (loss) attributable to common shareholders $ (23,925 ) $ (12,703 ) $ (15,901 ) $ (66,812 ) $ (23,498 )
 
Net income (loss) per share attributable to common shareholders - basic $ (1.99 ) $ (1.24 ) $ (1.61 ) $ (6.33 ) $ (2.40 )
Net income (loss) per share attributable to common shareholders - fully diluted $ (1.99 ) $ (1.24 ) $ (1.61 ) $ (6.33 ) $ (2.40 )
 
Weighted average shares outstanding - basic 12,021 10,236 9,879 10,559 9,792
Weighted average shares outstanding - diluted 12,021 10,236 9,879 10,559 9,792
 
(1) Includes stock-based compensation:

Cost of product revenue $ - $ - $ 4 $ - $ 9
Cost of service revenue 1 1 186 19 1,789
Research and development 328 (271 ) 723 339 1,723
Selling, general and administrative 343 244 533 1,284 2,253


Source: Transmeta  
Category: Business / Industry [ next ] [ previous ] [ top ] [ bottom ]

 Transmeta Reports Third Quarter 2007 Results Thu Nov 08, 04:53:44 PM  
   Author: M. Page

Transmeta Reports Third Quarter 2007 Results

Transmeta Corporation (NASDAQ:TMTA) today announced financial results for the third quarter of fiscal 2007, ended September 30, 2007.

Revenue for the third quarter of 2007 was $44,000, which included $43,000 of services revenue and $1,000 of license revenue for royalty payments. This compared with revenue of $171,000 in the second quarter of 2007, which included $146,000 of services revenue and $25,000 of end-of-life product revenue.

All share and per share data included in this press release have been retroactively adjusted to account for the effect of the one-for-20 reverse stock split that the Company effected on August 17, 2007. Net loss attributable to common shareholders for the third quarter of 2007 was $12.7 million, or a loss of $1.24 per share, compared with a net loss of $11.5 million, or a loss of $1.15 per share, in the second quarter of 2007. The third quarter of 2007 results included restructuring charges totaling $109,000, non-cash charges of $1.7 million for amortization of intangible assets and non-cash charges of $3.6 million for the beneficial conversion feature of the Series B Preferred Stock sold to AMD in July 2007.

Gross margin for the third quarter of 2007 was 59 percent, compared with a gross margin of 53 percent in the second quarter of 2007.

The Companys cash, cash equivalents and short term investments at September 30, 2007 totaled $28.6 million, including the approximate $7.0 million in net proceeds that Transmeta received from AMDs investment in the Company in July 2007, and the approximate $11.6 million in net proceeds that the Company received from its securities offering in September 2007. The Company continues to be debt free.

In October, Transmeta entered into an agreement with Intel Corporation providing for a settlement of all claims between the two companies and for the licensing of the Transmeta patent portfolio to Intel for use in current and future Intel products. The agreement will grant Intel a perpetual non-exclusive license to all Transmeta patents and patent applications, including any patent rights later acquired by Transmeta, now existing or as may be filed during the next ten years. Under the agreement, Transmeta will grant to Intel a non-exclusive paid-up license and transfer technology related to its LongRun and LongRun2 technologies and future improvements. Under the agreement, Intel will covenant not to sue Transmeta for the development and licensing to third parties of Transmetas LongRun and LongRun2 technologies. The agreement provides for Intel to make an initial $150 million payment to Transmeta as well as to pay Transmeta an annual license fee of $20 million for each of the next five years.

During the third quarter, we reinforced our relationship with AMD through the strategic investment that AMD made in Transmeta in July 2007. In addition, we raised about $11.6 million in net proceeds from our securities offering in September 2007 and completed the restructuring program that we started earlier this year, said Les Crudele, president and CEO. In October, we resolved our patent litigation with Intel, pursuant to an agreement that provides for Transmeta to receive an initial payment of $150 million and future payments of $20 million per year for each of the next five years. We believe these funds will give us the financial flexibility to execute on our strategy of developing and licensing our intellectual property. Having completed our restructuring, resolved our patent litigation, and taken steps to significantly strengthen our balance sheet, we can now concentrate our attention on developing our technology, building our licensing business, putting the building blocks in place to expand our customer base and creating long-term shareholder value.

Conference Call

As previously announced, Transmetas management will host a conference call today at 5:00 p.m. Eastern time / 2:00 p.m. Pacific time to discuss the operating performance for the quarter. The conference call will be available live over the Internet at the investor relations section of Transmeta's website at www.transmeta.com. To listen to the conference call, please dial (913) 312-0697. A recording of the conference call will be available for one week, starting one hour after the completion of the call, until 11:59 p.m. Pacific time on November 14, 2007. The phone number to access the recording is (888) 203-1112, and the passcode is 4283177. For callers outside the U.S., please dial (719) 457-0820, with the same passcode.

About Transmeta Corporation

Transmeta Corporation develops and licenses innovative computing, microprocessor and semiconductor technologies and related intellectual property. Founded in 1995, we first became known for designing, developing and selling our highly efficient x86-compatible software-based microprocessors, which deliver a balance of low power consumption, high performance, low cost and small size suited for diverse computing platforms. We are presently focused on developing and licensing our advanced power management technologies for controlling leakage and increasing power efficiency in semiconductor and computing devices, and in licensing our computing and microprocessor technologies to other companies. To learn more about Transmeta, visit www.transmeta.com.

Safe Harbor Statement

This release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements speak only as of the date of this release, and we will not necessarily provide updates of our projections or other forward-looking statements. Investors are cautioned that such forward-looking statements are subject to many risks and uncertainties, and may differ materially or adversely from our actual results or future events. Important risk factors that could have material or adverse effects on our results include practical difficulties in implementing our restructuring plan and modifying our business model, the potential loss of key technical and business personnel, uncertainty about the adoption and market acceptance of our technology offerings by current and potential customers and licensees, our inability to predict or ensure that third parties will license our technologies or use our technologies to generate royalties, difficulties in developing our technologies in a timely and cost effective manner, patents and other intellectual property rights, and other risk factors. We urge investors to review our filings with the Securities and Exchange Commission, including our most recent reports on Forms 10-K, 10-Q and 8-K, which describe these and other important risk factors that could have an adverse effect on our results. We undertake no obligation to revise or update publicly any forward-looking statement for any reason.

Transmeta and LongRun2 are trademarks of Transmeta Corporation. All other product or service names mentioned herein are the trademarks of their respective owners.

Transmeta Corporation
Condensed Consolidated Balance Sheets
(in thousands)
   
 
September 30, 2007 December 31, 2006
(Unaudited) (1)
ASSETS
Current assets:
Cash and cash equivalents $ 19,629 $ 11,595
Short-term investments 8,976 29,955
Accounts receivable, net 45 310
Prepaid and other current assets 2,332 2,729
Total current assets 30,982 44,589
 
Property, plant and equipment, net 376 758
Patents and patent rights, net 4,100 9,234
Other assets 1,010 2,148
TOTAL ASSETS $ 36,468 $ 56,729
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
Accounts payable $ 2,171 $ 1,467
Accrued compensation and related compensation liabilities 834 3,245
Deferred income, net - 15
Other accrued liabilities 4,388 3,015
Advances from customers - 1,320
Current portion of accrued restructuring costs 2,592 1,996
Current portion of long-term payables 600 667
Total current liabilities 10,585 11,725
 
Long-term accrued restructuring costs, net of current portion - 988
Long-term payables, net of current portion 1,000 1,333
Total liabilities 11,585 14,046
 
Stockholders' equity:
Preferred stock 6,966 -
Common stock 738,625 724,229
Treasury stock (2,439) (2,439)
Accumulated other comprehensive gain (loss) 29 (66)
Accumulated deficit (718,298) (679,041)
Total stockholders' equity 24,883 42,683
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 36,468 $ 56,729
 

(1) Derived from the Company's audited statements as of December 31, 2006, included in the Company's Form 10-K filed with the Securities and Exchange Commission.

Transmeta Corporation
Consolidated Statements of Operations
(Dollars in thousands, except per share data)
(Unaudited)
         
Three Months Ended Nine Months Ended
September 30, 2007 June 30, 2007 September 30, 2006   September 30, 2007 September 30, 2006
Revenue:
Product $ - $ 25 $ 507 $ 167 $ 1,457
License 1 - 10,000 1 10,000
Service 43 146 6,810 2,186 34,700
Total revenue 44 171 17,317 2,354 46,157
 
Cost of revenue:
Product (1) - - 9 80 109
License - - 39 - 39
Service (1) 18 80 3,913 1,236 20,589
Impairment charge on inventories - - - 364 -
Total cost of revenue 18 80 3,961 1,680 20,737
Gross profit 26 91 13,356 674 25,420
Gross margin % 59.1% 53.2% 77.1% 28.6% 55.1%
 
Operating expenses:
Research and development (1) 1,336 2,537 4,838 8,809 12,859
Selling, general and administrative (1) 6,107 5,644 4,847 17,857 16,434
Restructuring charges, net 109 1,920 107 8,694 277
Amortization of patents and patent rights 1,711 1,711 1,711 5,134 5,134
Impairment charge on long-lived and other assets - 8 - 302 -
Total operating expenses 9,263 11,820 11,503 40,796 34,704
Operating (loss) income (9,237) (11,729) 1,853 (40,122) (9,284)
Interest income and other, net 247 365 708 1,102 1,801
Interest expense (83) (86) (42) (237) (114)
Net income (loss) (9,073) (11,450) 2,519 (39,257) (7,597)
Deemed dividend for beneficial conversion feature of preferred stock (3,630) - - (3,630) -
Net income (loss) attributable to common shareholders $ (12,703) $ (11,450) $ 2,519 $ (42,887) $ (7,597)
 
Net income (loss) per share attributable to common shareholders--basic $ (1.24) $ (1.15) $ 0.26 $ (4.26) $ (0.78)

Net income (loss) per share attributable to common shareholders--fully diluted $ (1.24) $ (1.15) $ 0.25 $ (4.26) $ (0.78)
 
 
Weighted average shares
outstanding - basic 10,236 9,997 9,832 10,066 9,763
 
Weighted average shares
outstanding - fully diluted 10,236 9,997 9,990 10,066 9,763
 
 
 
(1) Includes charges for stock-based compensation:
 
Three Months Ended Nine Months Ended
September 30, 2007 June 30, 2007 September 30, 2006   September 30, 2007 September 30, 2006
Cost of product revenue $ - $ - $ (4) $ - $ 5
Cost of service revenue 1 14 239 18 1,603
Research and Development (271) 364 339 11 1,000
Selling, general and administrative 244 315 527 941 1,720
         
Total stock-based compensation $ (26) $ 693 $ 1,101 $ 970 $ 4,328


Source: Transmeta  
Category: Business / Industry [ next ] [ previous ] [ top ] [ bottom ]

 Thermalright IFX-14 CPU Cooler Review Mon Oct 29, 04:09:10 AM  
   Author: M. Page

“If you have not heard of Thermalright they make some of the most unique and powerful CPU coolers on the market today. They really specialize in heatsink design, a lot of their coolers perform great without fans. Most of them don't even ship with fans. Their latest offering is the IFX-14 (Inferno Fire eXtinguisher), which features an extremely large surface area (140mm x 120mm), 4 large 8mm heatpipes, and a very unique back-side dual heatpipe heatsink.”

Source: thinkcomputers  
Category: CPU / Processors [ next ] [ previous ] [ top ] [ bottom ]

 OQO First to Ship 1.6GHz VIA C7-M ULV Processor Sat Sep 15, 07:17:36 AM  
   Author: M. Page

VIA Technologies, Inc, a leading innovator and developer of silicon chip technologies and PC platform solutions, today announced that OQO Inc. is the first manufacturer to ship the 1.6GHz VIA C7-M ULV processor in the latest configurations of its award-winning model 02 product line. The higher-speed processor in this update of the OQO model 02 – the world’s smallest full-featured Windows Vista® PC – further increases the device’s performance and thus enables mobile professionals to enhance their anytime/anywhere productivity. In addition to a faster processor, the OQO model 02 update now also features configurations with options such as support for the super fast “EVDO Rev. A” high-speed wireless transmission standard, which delivers data rates of up to 1.4Mbps, improved upstream speed and lower latency. The update also offers enhanced storage capacity of up to 120GB, and an SSD (solid state drive) option is also available. “We are delighted that OQO has adopted our 1.6GHz VIA C7-M ULV processor for their model 02 computer,” commented Richard Brown, Vice President of Corporate Marketing, VIA Technologies, Inc. “This provides further evidence of our leadership in developing cutting-edge platforms for the rapidly growing UMD market.” “We have once again extended the performance envelope of ultra mobile computing,” said Bob Rosin, senior vice president of marketing & alliances, OQO. “With its faster CPU, increased hard drive capacities, SSD option and improved wireless capability, the new model 02 is the ultimate device for mobile professionals who want access to all their information, applications and the Internet wherever they go.”

Source: youtube  
Category: Mobile Devices [ next ] [ previous ] [ top ] [ bottom ]

 OQO Model 02 Ultra Mobile PC Mon Aug 20, 04:38:36 PM  
   Author: M. Page

"The OQO Model 02 clearly isn't for everyone. But if you need more power than a smartphone, want a built-in keyboard and the power of a Windows PC in your pocket, then it's a straight fight between the OQO and Sony's UX1XN. The latter is the more powerful and fully featured device but OQO's Model 02 has taken the desirability of the original model up a notch and has made it much more usable."

Source: trustedreviews  
Category: Mobile Devices [ next ] [ previous ] [ top ] [ bottom ]

 Transmeta Announces Reverse Stock Split Thu Aug 16, 03:23:12 PM  
   Author: M. Page

Transmeta Corporation (NASDAQ: TMTA) today announced that its Board of Directors has approved a reverse split of Transmeta’s common stock at a ratio of one-for-20 shares, to take effect on Friday, August 17, 2007. At its annual meeting of stockholders held on July 31, 2007, Transmeta received stockholder approval of a proposal authorizing the Transmeta Board of Directors, in its discretion, to effect a reverse split of Transmeta’s common stock, at a ratio within the range from one-for-10 to one-for-40 shares, together with a corresponding reduction in the number of authorized shares of Transmeta’s capital stock, at any time prior to July 31, 2008. The reverse stock split will be effective at 8:00 a.m., Eastern Time, on August 17, 2007. Transmeta’s common stock will begin trading at that time on a reverse split basis under the symbol "TMTAD," for a period of 20 trading days. Thereafter, it will resume trading under the Company's original symbol "TMTA." The reverse split will reduce the number of outstanding shares of Transmeta’s common stock from approximately 200 million shares to approximately 10 million shares. No fractional shares will be issued in connection with the reverse stock split. Cash will be issued in lieu of fractional shares. The exercise price and the number of shares of common stock issuable under the Company's outstanding warrants and options will be proportionately adjusted to reflect the reverse stock split. The number of shares issuable upon conversion of Transmeta’s Series B preferred stock and issuable under the Company’s equity incentive plans will be proportionately reduced to reflect the reverse stock split. Additional information about the reverse stock split is available in Transmeta’s definitive proxy statement filed with the Securities and Exchange Commission on June 29, 2007. Existing stockholders holding Transmeta common stock certificates will receive a Letter of Transmittal from the Company’s transfer agent, with specific instructions regarding the exchange of shares. Mellon Investor Services LLC is Transmeta’s transfer agent and will act as the exchange agent for the purpose of implementing the exchange of stock certificates in connection with the reverse split. About Transmeta Corporation

Source: transmeta  
Category: Business / Industry [ next ] [ previous ] [ top ] [ bottom ]

 Transmeta Reports Second Quarter 2007 Results Wed Aug 08, 03:44:37 PM  
   Author: M. Page

Transmeta Corporation (NASDAQ: TMTA) today announced financial results for the second quarter of fiscal 2007, ended June 30, 2007.

Revenue for the second quarter of 2007 was $171,000, which included $146,000 of service revenue and $25,000 of end-of-life product revenue. This compared with revenue of $2.1 million in the first quarter of 2007, which included $2.0 million of service revenue and $140,000 of end-of-life product revenue. Net loss for the second quarter of 2007 was $11.5 million, or a loss of $0.06 per share, compared with a net loss of $18.7 million, or a loss of $0.09 per share, in the first quarter of 2007. The second quarter of 2007 results included restructuring charges totaling $1.9 million, non-cash charges of $1.7 million for amortization of intangible assets and $693,000 for stock-based compensation expenses.

Gross margin for the second quarter of 2007 was 53 percent, compared with a gross margin of 26 percent in the first quarter of 2007. The sequential increase in gross margin is primarily due to two items: the first quarter 2007 included a one-time $364,000 impairment charge, and the second quarter revenue included higher margin product revenue from inventories that were previously written-off and fully reserved.

The Company's cash, cash equivalents and short term investments at June 30, 2007 totaled $15.3 million. The Company continues to be debt free. Cash at June 30, 2007 does not include the approximate $7.0 million in net proceeds that Transmeta received from AMD's investment in the Company in July 2007.

"In the first half of 2007 we made significant progress to reduce our spending by streamlining our operations to focus on developing and licensing our technologies and intellectual property,' said Les Crudele, president and CEO. "In addition, we continue to focus our efforts on strengthening our balance sheet, which was recently improved by the strategic investment by AMD. We are pleased with AMD’s investment in the future of Transmeta, and we will continue to explore additional opportunities to finance our operations.

"The progress we have made enables us to now bring even greater focus on developing our technology, building our licensing business and expanding our customer base. We continue to have a number of LongRun2 licensing opportunities in various stages of discussion and are pleased that our first royalty licensee, NEC Electronics, expects to move to volume production of its M2 mobile phone chip in the fourth quarter of this year," said Mr. Crudele.

2007 Annual Meeting Results

Transmeta Corporation held its Annual Meeting of Stockholders on Monday, July 31, 2007 as scheduled. A quorum of stockholders was present in person or by proxy. During the meeting, the motion to elect Messrs. Barnes and Goldman as members in Class I of the Board of Directors of the Company was approved. In addition, the proposal submitted to the stockholders, allowing the Company's Board of Directors to effectuate a reverse stock split at any time prior to July 31, 2008 was approved. There were also sufficient votes to ratify the appointment of Burr, Pilger & Mayer as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2007. A complete tally of the votes on each of these measures will be published in the Company's next regular report on Form 10-Q for the quarterly period ending September 30, 2007, which is expected to be filed with the Securities and Exchange Commission in November 2007.

Conference Call

As previously announced, Transmeta's management will host a conference call today at 5:00 p.m. Eastern time / 2:00 p.m. Pacific time to discuss the operating performance for the quarter. The conference call will be available live over the Internet at the investor relations section of Transmeta's website at www.transmeta.com. To listen to the conference call, please di